Seach Medical Group Temettü
Temettü kriter kontrolleri 0/6
Seach Medical Group does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
n/a
Geri Alım Getirisi
Toplam Hissedar Getirisi | n/a |
Gelecekteki Temettü Verimi | n/a |
Temettü Büyümesi | n/a |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Seach Medical Group Ltd's (TLV:SEMG) 26% Price Boost Is Out Of Tune With Revenues
Oct 30Investors Still Aren't Entirely Convinced By Seach Medical Group Ltd's (TLV:SEMG) Revenues Despite 27% Price Jump
Aug 28Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Aug 13Fewer Investors Than Expected Jumping On Seach Medical Group Ltd (TLV:SEMG)
Jun 02Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Feb 21Is Seach Medical Group (TLV:SEMG) A Risky Investment?
Oct 12Seach Medical Group (TLV:SEMG) Has Debt But No Earnings; Should You Worry?
Jul 14Seach Medical Group (TLV:SEMG) Has A Pretty Healthy Balance Sheet
Feb 27Seach Medical Group Ltd's (TLV:SEMG) Share Price Not Quite Adding Up
May 13Seach Medical Group's (TLV:SEMG) Shareholders Have More To Worry About Than Lackluster Earnings
Dec 02Declining Stock and Decent Financials: Is The Market Wrong About Seach Medical Group Ltd (TLV:SEMG)?
Mar 18Seach Medical Group's(TLV:SEMG) Share Price Is Down 20% Over The Past Year.
Jan 22Has Seach Medical Group Ltd (TLV:SEMG) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Dec 18Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if SEMG's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if SEMG's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Seach Medical Group Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (SEMG) | n/a |
Pazarın Alt %25'i (IL) | 2.4% |
Pazarın En İyi %25'i (IL) | 6.5% |
Sektör Ortalaması (Pharmaceuticals) | 1.8% |
Analist tahmini (SEMG) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate SEMG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate SEMG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate SEMG's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as SEMG has not reported any payouts.